Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Clinical Pharmacokinetics|September 25, 1999
Clinical pharmacokinetics of troglitazoneC M Loi, M Young, E Randinitis, et al.British Journal of Clinical Pharmacology|April 1, 1993
The effect of tocainide on theophylline metabolismC M Loi, X Wei, B M Parker, et al.Journal of Clinical Pharmacology|April 10, 1999
Effect of troglitazone on the pharmacokinetics of an oral contraceptive agentC M Loi, R Stern, J R Koup, et al.Journal of Clinical Pharmacology|March 20, 1998
Meta-analysis of steady-state pharmacokinetics of troglitazone and its metabolitesC M Loi, C W Alvey, E J Randinitis, et al.Journal of Clinical Pharmacology|March 20, 1998
Lack of effect of type II diabetes on the pharmacokinetics of troglitazone in a multiple-dose studyC M Loi, E J Randinitis, A B Vassos, et al.Journal of Clinical Pharmacology|September 3, 1999
Steady-state pharmacokinetics and dose proportionality of troglitazone and its metabolitesC M Loi, C W Alvey, A B Vassos, et al.Journal of Clinical Pharmacology|February 1, 1997
Acetylator phenotype in relation to age and gender in the Baltimore Longitudinal Study of AgingM R Korrapati, J D Sorkin, R Andres, et al.Journal of Clinical Pharmacology|April 29, 1998
Effect of troglitazone on steady-state pharmacokinetics of digoxinC M Loi, P W Knowlton, R Stern, et al.Clinical Pharmacology and Therapeutics|May 1, 1989
Dose-dependent inhibition of theophylline metabolism by disulfiram in recovering alcoholicsC M Loi, J D Day, S G Jue, et al.Pharmacogenetics|December 12, 2001
In-vivo phenotyping for CYP3A by a single-point determination of midazolam plasma concentrationY S Lin, G F Lockwood, M A Graham, et al.Pageof 2